文献
J-GLOBAL ID:201102281143547220
整理番号:11A1128626
BRCA1またはBRCA2変異および進行乳癌患者における経口ポリ(ADP-リボース)ポリメラーゼ阻害剤,オラパリブ:概念実証試験
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: A proof-of-concept trial
著者 (15件):
TUTT A.
(Breakthrough Breast Cancer Res. Unit, London, GBR)
,
ROBSON M.
(Memorial Sloan-Kettering Cancer Center, NY, USA)
,
GARBER J.E.
(Dana-Farber Cancer Inst., MA, USA)
,
DOMCHEK S.M.
(Univ. Pennsylvania, PA, USA)
,
AUDEH M.W.
(Cedars-Sinai Medical Center, CA, USA)
,
WEITZEL J.N.
(City of Hope Comprehensive Cancer Center, CA, USA)
,
FRIEDLANDER M.
(Prince of Wales Cancer Centre, NSW, AUS)
,
ARUN B.
(MD Anderson Cancer Center, TX, USA)
,
LOMAN N.
(Lund Univ., Lund, SWE)
,
SCHMUTZLER R.K.
(Univ. Cologne, Cologne, DEU)
,
WARDLEY A.
(Christie Hospital NHS Foundation Trust, Manchester, GBR)
,
MITCHELL G.
(MacCallum Cancer Centre, VIC, AUS)
,
EARL H.
(Univ. Cambridge, Cambridge, GBR)
,
WICKENS M.
(AstraZeneca, Macclesfield, GBR)
,
CARMICHAEL J.
(AstraZeneca, Macclesfield, GBR)
資料名:
Lancet
(Lancet)
巻:
376
号:
9737
ページ:
235-244
発行年:
2010年
JST資料番号:
B0673A
ISSN:
0140-6736
CODEN:
LANCA
資料種別:
逐次刊行物 (A)
発行国:
オランダ (NLD)
言語:
英語 (EN)